GW Pharma files cannabis drug for MS in Europe | Reuters
Links shared publicly online about this topic.
- 2,031total visits
GW Pharma files cannabis drug for MS in Europe | Reuters
LONDON (Reuters) - A pioneering cannabis-based medicine for multiple sclerosis from GW Pharmaceuticals has been filed for approval in Europe, paving the way for its potential approval at the end of 2009
View full resource at reuters.com
Tags: Multiple Sclerosis, Drug, Pharma
Most Recently Shared on May 20, 2009 at 7:56 am By:
High times for Britain's GW Pharmaceuticals - its under-the-tongue cannabis spray is filed in Europe, stock up 9% http://tinyurl.com/ofzq7u
Advertisement
